nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0853	0.0853	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—DRD4—conduct disorder	0.0575	0.0575	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—DRD4—conduct disorder	0.0562	0.0562	CbGpPWpGaD
Indacaterol—ADRB1—Melatonin metabolism and effects—MAOA—conduct disorder	0.051	0.051	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0483	0.0483	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0473	0.0473	CbGpPWpGaD
Indacaterol—ADRB1—Monoamine GPCRs—HTR2A—conduct disorder	0.0375	0.0375	CbGpPWpGaD
Indacaterol—ADRB2—Monoamine GPCRs—HTR2A—conduct disorder	0.0367	0.0367	CbGpPWpGaD
Indacaterol—ADRB1—G alpha (s) signalling events—CGA—conduct disorder	0.0356	0.0356	CbGpPWpGaD
Indacaterol—ADRB2—G alpha (s) signalling events—CGA—conduct disorder	0.0348	0.0348	CbGpPWpGaD
Indacaterol—ADRB1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0315	0.0315	CbGpPWpGaD
Indacaterol—ADRB2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0308	0.0308	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Other—DRD4—conduct disorder	0.025	0.025	CbGpPWpGaD
Indacaterol—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0241	0.0241	CbGpPWpGaD
Indacaterol—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.024	0.024	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.0211	0.0211	CbGpPWpGaD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0173	0.0173	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.017	0.017	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0166	0.0166	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Other—HTR2A—conduct disorder	0.0163	0.0163	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—COMT—conduct disorder	0.014	0.014	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.0139	0.0139	CbGpPWpGaD
Indacaterol—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.0138	0.0138	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CGA—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CGA—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0111	0.0111	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0109	0.0109	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00951	0.00951	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0093	0.0093	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00741	0.00741	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.0073	0.0073	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00724	0.00724	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.00724	0.00724	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CGA—conduct disorder	0.00715	0.00715	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00708	0.00708	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—DRD4—conduct disorder	0.00708	0.00708	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.00663	0.00663	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CGA—conduct disorder	0.00649	0.00649	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0062	0.0062	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00607	0.00607	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00593	0.00593	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CGA—conduct disorder	0.00531	0.00531	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00488	0.00488	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	0.00472	0.00472	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	0.00462	0.00462	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	0.00409	0.00409	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	0.004	0.004	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00396	0.00396	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00393	0.00393	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CGA—conduct disorder	0.00392	0.00392	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00391	0.00391	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CGA—conduct disorder	0.00383	0.00383	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—DRD4—conduct disorder	0.00371	0.00371	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—DRD4—conduct disorder	0.00363	0.00363	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—WASF1—conduct disorder	0.00314	0.00314	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—WASF1—conduct disorder	0.00307	0.00307	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	0.00267	0.00267	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	0.00261	0.00261	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00254	0.00254	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CGA—conduct disorder	0.00244	0.00244	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	0.00242	0.00242	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—COMT—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—MAOA—conduct disorder	0.00238	0.00238	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	0.00237	0.00237	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DRD4—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DRD4—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CGA—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HTR2A—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HTR2A—conduct disorder	0.0014	0.0014	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—COMT—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MAOA—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—EP300—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EP300—conduct disorder	0.000759	0.000759	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EP300—conduct disorder	0.000742	0.000742	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—COMT—conduct disorder	0.000678	0.000678	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MAOA—conduct disorder	0.000673	0.000673	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—EP300—conduct disorder	0.000472	0.000472	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—EP300—conduct disorder	0.000291	0.000291	CbGpPWpGaD
